Andrea Aliverti
Overview
Explore the profile of Andrea Aliverti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
226
Citations
2422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Qi W, Xu X, Qian K, Schuller B, Fortino G, Aliverti A
IEEE J Biomed Health Inform
. 2024 May;
PP.
PMID: 38809724
This scoping review paper redefines the Artificial Intelligence-based Internet of Things (AIoT) driven Human Activity Recognition (HAR) field by systematically extrapolating from various application domains to deduce potential techniques and...
12.
Serrani A, Aliverti A
Sensors (Basel)
. 2024 May;
24(9).
PMID: 38732888
In today's health-monitoring applications, there is a growing demand for wireless and wearable acquisition platforms capable of simultaneously gathering multiple bio-signals from multiple body areas. These systems require well-structured software...
13.
Farina G, Galli M, Borsari L, Aliverti A, Paraskevopoulos I, LoMauro A
Bioengineering (Basel)
. 2024 Apr;
11(4).
PMID: 38671803
Background: Accurate measurements of limb volumes are important for clinical reasons. We aimed to assess the reliability and validity of two centimetric and two optoelectronic techniques for limb volume measurements...
14.
Bernasconi S, Angelucci A, De Cesari A, Masotti A, Pandocchi M, Vacca F, et al.
Diagnostics (Basel)
. 2024 Apr;
14(8).
PMID: 38667431
The measurement of partial pressures of oxygen (O) and carbon dioxide (CO) is fundamental for evaluating a patient's conditions in clinical practice. There are many ways to retrieve O/CO partial...
15.
Bayartai M, Luomajoki H, Aliverti A, LoMauro A, Tringali G, Sartorio A
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610900
Achondroplasia is a rare genetic disease, yet the most common form of dwarfism, characterized by limb shortening and disproportionate short stature along with musculoskeletal changes, such as postural deviations. Although...
16.
Pennati F, Belenkov S, Buccardi M, Ferrini E, Sverzellati N, Villetti G, et al.
iScience
. 2024 Mar;
27(3):109262.
PMID: 38433926
Micro-computed tomography derived functional biomarkers used in lung disease research can significantly complement end-stage histomorphometric measures while also allowing for longitudinal studies. However, no approach for visualizing lung dynamics across...
17.
Santini A, Protti A, Pennati F, Dalla Corte F, Martinetti N, Pugliese L, et al.
Acta Anaesthesiol Scand
. 2024 Mar;
68(5):626-634.
PMID: 38425207
Background: High positive end-expiratory pressure (PEEP>10 cmHO) is commonly used in mechanically ventilated hypoxemic patients with COVID-19. However, some epidemiological and physiological studies indirectly suggest that using a lower PEEP...
18.
Zhang X, Sridhar A, Ha X, Mehdi S, Fortuna A, Magro M, et al.
Int J Comput Assist Radiol Surg
. 2024 Feb;
19(4):757-766.
PMID: 38386176
Purpose: Intracardiac transcatheter interventions allow for reducing trauma and hospitalization stays as compared to standard surgery. In the treatment of mitral regurgitation, the most widely adopted transcatheter approach consists in...
19.
Angelucci A, Canali S, Aliverti A
Front Digit Health
. 2023 Dec;
5:1330189.
PMID: 38152629
Step counting is among the fundamental features of wearable technology, as it grounds several uses of wearables in biomedical research and clinical care, is at the center of emerging public...
20.
Angelucci A, Pongiglione B, Bernasconi S, Carrone F, Mazziotti G, Costantino M, et al.
Digit Health
. 2023 Dec;
9:20552076231218858.
PMID: 38107981
Objective: The aim of the study was to develop an app to improve patients' adherence to therapy for osteoporosis and to test its usability. Methods: In Phase I, the app...